Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | +2.34% | +6.24% | -30.32% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 1.5M | Capitalization | 84.33M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -122M | EV / Sales 2024 * | - |
Net cash position 2024 * | 37.38M | Net cash position 2025 * | 266M | EV / Sales 2025 * | -121 x |
P/E ratio 2024 * |
-1.06
x | P/E ratio 2025 * |
-1.11
x | Employees | 70 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.77% |
Latest transcript on IO Biotech, Inc.
1 day | +2.34% | ||
1 week | +6.24% | ||
Current month | +11.02% | ||
1 month | -9.03% | ||
3 months | -22.94% | ||
6 months | +0.07% | ||
Current year | -30.32% |
Managers | Title | Age | Since |
---|---|---|---|
Mai-Britt Zocca
FOU | Founder | 56 | 14-11-30 |
Amy Sullivan
DFI | Director of Finance/CFO | 54 | 22-10-14 |
Eric Faulkner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
David Smith
BRD | Director/Board Member | 64 | 22-02-28 |
K. Hirth
CHM | Chairman | 72 | 16-08-31 |
Kathleen Glaub
BRD | Director/Board Member | 70 | 18-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 1.31 | +2.34% | 180,147 |
24-06-13 | 1.28 | 0.00% | 35,764 |
24-06-12 | 1.28 | -3.03% | 53,998 |
24-06-11 | 1.32 | +6.45% | 66,181 |
24-06-10 | 1.24 | +0.57% | 54,342 |
Delayed Quote Nasdaq, June 14, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.32% | 84.33M | |
+40.80% | 55.66B | |
-8.05% | 38.98B | |
+35.79% | 38.8B | |
-8.98% | 27.32B | |
+10.69% | 26.29B | |
-16.21% | 20.25B | |
+31.00% | 12.76B | |
+28.51% | 12.18B | |
-1.67% | 12.12B |
- Stock Market
- Equities
- IOBT Stock